{"transactions":[{"id":3821,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-09-03T23:47:30.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":2127,"price":19.6564,"value":41809.1628,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $19.60 to $19.74, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":359924,"source":{"system":"sec-edgar","filing":"0001819718-26-000015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971826000015/ownership.xml","form_type":"4"}},{"id":673292,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-08-28T22:06:00.000Z","date":"2026-08-27","kind":"sale","planned":false,"acquired":false,"shares":1193,"price":19.9053,"value":23747.0229,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $19.83 to $20.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":362051,"source":{"system":"sec-edgar","filing":"0001819718-26-000011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971826000011/ownership.xml","form_type":"4"}},{"id":702525,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-07-28T20:32:09.000Z","date":"2026-07-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4361,"price":19.67,"value":85780.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":363244,"source":{"system":"sec-edgar","filing":"0001193125-26-321086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526321086/ownership.xml","form_type":"4"}},{"id":753066,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-06-03T21:29:54.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2146,"price":17.8855,"value":38382.283,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $17.63 to $18.10, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":367605,"source":{"system":"sec-edgar","filing":"0001819718-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971826000007/ownership.xml","form_type":"4"}},{"id":760739,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-05-28T21:22:08.000Z","date":"2026-05-27","kind":"sale","planned":false,"acquired":false,"shares":1201,"price":17.6,"value":21137.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $17.39 to $17.76, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":369751,"source":{"system":"sec-edgar","filing":"0001819718-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971826000003/ownership.xml","form_type":"4"}},{"id":799285,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-04-28T20:52:04.000Z","date":"2026-04-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4361,"price":16.31,"value":71127.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":370952,"source":{"system":"sec-edgar","filing":"0001193125-26-187448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526187448/ownership.xml","form_type":"4"}},{"id":875330,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-03T01:01:26.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8147,"price":15.33,"value":124893.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."}],"balance_after":375313,"source":{"system":"sec-edgar","filing":"0001819718-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971826000001/ownership.xml","form_type":"4"}},{"id":875329,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-03T01:01:26.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1079,"price":15.33,"value":16541.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":383460,"source":{"system":"sec-edgar","filing":"0001819718-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971826000001/ownership.xml","form_type":"4"}},{"id":875328,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-03T01:01:26.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1140,"price":24.76,"value":28226.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."}],"balance_after":384539,"source":{"system":"sec-edgar","filing":"0001819718-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971826000001/ownership.xml","form_type":"4"}},{"id":882655,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":31962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":385679,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":882654,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":14751,"price":23.09,"value":340600.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025."}],"balance_after":353717,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":882653,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":8254,"price":23.09,"value":190584.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024."}],"balance_after":368468,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":882652,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3163,"price":23.09,"value":73033.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023."}],"balance_after":376722,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":882651,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":27341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025."}],"balance_after":379885,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":882650,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":15299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024."}],"balance_after":352544,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":882649,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":5862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023."}],"balance_after":337245,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":882648,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-26T01:18:12.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":655,"price":23.01,"value":15071.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":331383,"source":{"system":"sec-edgar","filing":"0001193125-26-072640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526072640/ownership.xml","form_type":"4"}},{"id":929363,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-01-28T22:02:08.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4711,"price":27.53,"value":129693.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":332038,"source":{"system":"sec-edgar","filing":"0001193125-26-027402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312526027402/ownership.xml","form_type":"4"}},{"id":982538,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-12-03T22:04:34.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1140,"price":28.3318,"value":32298.252,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $28.27 to $28.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":336749,"source":{"system":"sec-edgar","filing":"0001193125-25-306921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312525306921/ownership.xml","form_type":"4"}},{"id":985601,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-12-02T02:14:51.000Z","date":"2025-11-28","kind":"sale","planned":false,"acquired":false,"shares":1198,"price":29.5695,"value":35424.261,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $29.45 to $29.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":337889,"source":{"system":"sec-edgar","filing":"0001193125-25-304294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312525304294/ownership.xml","form_type":"4"}},{"id":989253,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-11-25T21:30:06.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":681,"price":30.473,"value":20752.113,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $30.33 to $30.62, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":339087,"source":{"system":"sec-edgar","filing":"0001193125-25-297323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312525297323/ownership.xml","form_type":"4"}},{"id":991750,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-11-21T21:30:06.000Z","date":"2025-11-19","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects shares transferred as a gift to the James and Karena Xie Family Foundation (the \"Foundation\"), of which, the reporting person is the president and has voting and investment power over all securities owned by the foundation."}],"balance_after":339768,"source":{"system":"sec-edgar","filing":"0001193125-25-291451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312525291451/ownership.xml","form_type":"4"}},{"id":991749,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-11-21T21:30:06.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":29.0983,"value":290983.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person for year-end tax planning."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $29.07 to $29.1985, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":349768,"source":{"system":"sec-edgar","filing":"0001193125-25-291451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312525291451/ownership.xml","form_type":"4"}},{"id":1012842,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-28T21:20:12.000Z","date":"2025-10-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4353,"price":23.74,"value":103340.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":359768,"source":{"system":"sec-edgar","filing":"0001193125-25-253871","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000119312525253871/ownership.xml","form_type":"4"}},{"id":1050527,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-09-03T21:33:03.000Z","date":"2025-09-03","kind":"sale","planned":false,"acquired":false,"shares":1128,"price":22.0267,"value":24846.1176,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.92 to $22.175, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":364121,"source":{"system":"sec-edgar","filing":"0001819718-25-000022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971825000022/ownership.xml","form_type":"4"}},{"id":1054004,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-08-28T22:55:41.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":1199,"price":21.4847,"value":25760.1553,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.28 to $21.66, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":365249,"source":{"system":"sec-edgar","filing":"0001819718-25-000018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971825000018/ownership.xml","form_type":"4"}},{"id":1056172,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-08-26T23:13:23.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":696,"price":21.5016,"value":14965.1136,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.46 to $21.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":366448,"source":{"system":"sec-edgar","filing":"0001819718-25-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000181971825000008/ownership.xml","form_type":"4"}},{"id":1080220,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-07-29T22:04:27.000Z","date":"2025-07-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4352,"price":18.37,"value":79946.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":367144,"source":{"system":"sec-edgar","filing":"0000950170-25-099792","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025099792/ownership.xml","form_type":"4"}},{"id":1126259,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-06-03T20:46:32.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":1135,"price":20.2908,"value":23030.058,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $20.01 to $20.70, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":371496,"source":{"system":"sec-edgar","filing":"0000950170-25-081045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025081045/ownership.xml","form_type":"4"}},{"id":1132563,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-05-28T20:17:07.000Z","date":"2025-05-27","kind":"sale","planned":false,"acquired":false,"shares":1183,"price":20.5169,"value":24271.4927,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $20.445 to $20.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":372631,"source":{"system":"sec-edgar","filing":"0000950170-25-078349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025078349/ownership.xml","form_type":"4"}},{"id":1132562,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-05-28T20:17:07.000Z","date":"2025-05-27","kind":"sale","planned":false,"acquired":false,"shares":690,"price":20.5753,"value":14196.957,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $20.41 to $20.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":373814,"source":{"system":"sec-edgar","filing":"0000950170-25-078349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025078349/ownership.xml","form_type":"4"}},{"id":1164364,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-04-29T20:54:58.000Z","date":"2025-04-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4353,"price":18.88,"value":82184.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":374504,"source":{"system":"sec-edgar","filing":"0000950170-25-060281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025060281/ownership.xml","form_type":"4"}},{"id":1232033,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-05T01:10:52.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1481,"price":15.45,"value":22881.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":378857,"source":{"system":"sec-edgar","filing":"0000950170-25-032782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025032782/ownership.xml","form_type":"4"}},{"id":1232023,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-05T01:07:50.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4551,"price":16.24,"value":73908.24,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The original Form 4 filed on February 27, 2025 on behalf of the reporting person inadvertently reported an incorrect transaction date. As reported in this amendment, the correct transaction date is February 26, 2025."},{"field":"shares","element":"transactionShares","label":"F5","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."}],"balance_after":380338,"source":{"system":"sec-edgar","filing":"0000950170-25-032777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025032777/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-27"}},{"id":1232022,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-05T01:07:50.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":8031,"price":16.29,"value":130824.99,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The original Form 4 filed on February 27, 2025 on behalf of the reporting person inadvertently reported an incorrect transaction date. As reported in this amendment, the correct transaction date is February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of performance-based restricted stock units granted to the reporting person on February 26, 2024, which vesting was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."}],"balance_after":339585,"source":{"system":"sec-edgar","filing":"0000950170-25-032777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025032777/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-27"}},{"id":1232021,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-05T01:07:50.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2951,"price":16.29,"value":48071.79,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The original Form 4 filed on February 27, 2025 on behalf of the reporting person inadvertently reported an incorrect transaction date. As reported in this amendment, the correct transaction date is February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of performance-based restricted stock units granted to the reporting person on February 23, 2023, which vesting was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."}],"balance_after":347616,"source":{"system":"sec-edgar","filing":"0000950170-25-032777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025032777/ownership.xml","form_type":"4/A","original_submission_date":"2025-02-27"}},{"id":1241692,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4551,"price":16.24,"value":73908.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."}],"balance_after":380338,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1241691,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":45304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2025, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":384889,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1241690,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2024-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":8031,"price":16.29,"value":130824.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024."}],"balance_after":339585,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1241689,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2024-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2951,"price":16.29,"value":48071.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023."}],"balance_after":347616,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1241688,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1823,"price":16.29,"value":29696.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022."}],"balance_after":350567,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1241687,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":14297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024."}],"balance_after":352390,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1241686,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023."}],"balance_after":338093,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1241685,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:14.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":3384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022."}],"balance_after":332613,"source":{"system":"sec-edgar","filing":"0000950170-25-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025029434/ownership.xml","form_type":"4"}},{"id":1247557,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-02-25T22:26:37.000Z","date":"2025-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":719,"price":16.46,"value":11834.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":329229,"source":{"system":"sec-edgar","filing":"0000950170-25-026887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025026887/ownership.xml","form_type":"4"}},{"id":1293506,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-01-28T21:28:15.000Z","date":"2025-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4733,"price":17.21,"value":81454.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":329948,"source":{"system":"sec-edgar","filing":"0000950170-25-009840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017025009840/ownership.xml","form_type":"4"}},{"id":1343712,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-12-04T21:41:05.000Z","date":"2024-12-03","kind":"sale","planned":false,"acquired":false,"shares":1455,"price":19.4999,"value":28372.3545,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $19.46 to $19.58, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":334681,"source":{"system":"sec-edgar","filing":"0000950170-24-133311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024133311/ownership.xml","form_type":"4"}},{"id":1350052,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-11-27T22:00:03.000Z","date":"2024-11-25","kind":"sale","planned":false,"acquired":false,"shares":689,"price":18.2593,"value":12580.6577,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $18.12 to $18.50, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":336136,"source":{"system":"sec-edgar","filing":"0000950170-24-131590","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024131590/ownership.xml","form_type":"4"}},{"id":1380334,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-10-29T20:30:12.000Z","date":"2024-10-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4345,"price":19.42,"value":84379.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":336825,"source":{"system":"sec-edgar","filing":"0000950170-24-118286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024118286/ownership.xml","form_type":"4"}},{"id":1414590,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-09-05T20:21:29.000Z","date":"2024-09-03","kind":"sale","planned":false,"acquired":false,"shares":1594,"price":21.961,"value":35005.834,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.815 to $22.10, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":341170,"source":{"system":"sec-edgar","filing":"0000950170-24-104021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024104021/ownership.xml","form_type":"4"}},{"id":1420284,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-08-29T22:33:55.000Z","date":"2024-08-27","kind":"sale","planned":false,"acquired":false,"shares":715,"price":22.833,"value":16325.595,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $22.72 to $22.915, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":342764,"source":{"system":"sec-edgar","filing":"0000950170-24-101989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024101989/ownership.xml","form_type":"4"}},{"id":1439891,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-08-06T20:10:06.000Z","date":"2024-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6719,"price":25.06,"value":168378.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":343479,"source":{"system":"sec-edgar","filing":"0000950170-24-091805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024091805/ownership.xml","form_type":"4"}},{"id":1446669,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-07-30T20:29:20.000Z","date":"2024-07-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4345,"price":23.66,"value":102802.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":350198,"source":{"system":"sec-edgar","filing":"0000950170-24-087896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024087896/ownership.xml","form_type":"4"}},{"id":1493574,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-06-04T20:57:00.000Z","date":"2024-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":404,"price":20.65,"value":8342.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":354543,"source":{"system":"sec-edgar","filing":"0000950170-24-068794","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024068794/ownership.xml","form_type":"4"}},{"id":1493573,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-06-04T20:57:00.000Z","date":"2024-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1075,"price":20.65,"value":22198.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":354947,"source":{"system":"sec-edgar","filing":"0000950170-24-068794","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024068794/ownership.xml","form_type":"4"}},{"id":1501010,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-05-28T20:22:51.000Z","date":"2024-05-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":653,"price":21.14,"value":13804.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":356022,"source":{"system":"sec-edgar","filing":"0000950170-24-065241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024065241/ownership.xml","form_type":"4"}},{"id":1525209,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-05-07T20:22:26.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6719,"price":21.5,"value":144458.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":356675,"source":{"system":"sec-edgar","filing":"0000950170-24-054561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024054561/ownership.xml","form_type":"4"}},{"id":1533179,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-04-30T20:04:24.000Z","date":"2024-04-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4344,"price":20.1,"value":87314.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":363394,"source":{"system":"sec-edgar","filing":"0000950170-24-050516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024050516/ownership.xml","form_type":"4"}},{"id":1599373,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-03-05T21:28:31.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":404,"price":23.24,"value":9388.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":367738,"source":{"system":"sec-edgar","filing":"0000950170-24-026011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024026011/ownership.xml","form_type":"4"}},{"id":1599372,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-03-05T21:28:31.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1075,"price":23.24,"value":24983.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":368142,"source":{"system":"sec-edgar","filing":"0000950170-24-026011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024026011/ownership.xml","form_type":"4"}},{"id":1613324,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-29T00:10:24.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":25350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 26, 2024, and 1/12th of such shares vesting at the end of every three month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":369217,"source":{"system":"sec-edgar","filing":"0000950170-24-022463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024022463/ownership.xml","form_type":"4"}},{"id":1613323,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-29T00:10:24.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3418,"price":24.26,"value":82920.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023."}],"balance_after":343867,"source":{"system":"sec-edgar","filing":"0000950170-24-022463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024022463/ownership.xml","form_type":"4"}},{"id":1613322,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-29T00:10:24.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2111,"price":24.26,"value":51212.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022."}],"balance_after":347285,"source":{"system":"sec-edgar","filing":"0000950170-24-022463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024022463/ownership.xml","form_type":"4"}},{"id":1613321,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-29T00:10:24.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":6359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023."}],"balance_after":349396,"source":{"system":"sec-edgar","filing":"0000950170-24-022463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024022463/ownership.xml","form_type":"4"}},{"id":1613320,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-29T00:10:24.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":3927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022."}],"balance_after":343037,"source":{"system":"sec-edgar","filing":"0000950170-24-022463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024022463/ownership.xml","form_type":"4"}},{"id":1617077,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-27T23:52:59.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":2612,"price":24.06,"value":62844.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":339110,"source":{"system":"sec-edgar","filing":"0000950170-24-021519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024021519/ownership.xml","form_type":"4"}},{"id":1652099,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-09T23:09:10.000Z","date":"2021-03-11","kind":"sale","planned":false,"acquired":false,"shares":5700,"price":101.6631,"value":579479.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale of the shares occured in the fiscal year ended December 31, 2021, but the filing of the Form 4 was inadvertently missed during that period."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $100.28 to $104.09, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":353124,"source":{"system":"sec-edgar","filing":"0000950170-24-013414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024013414/ownership.xml","form_type":"5"}},{"id":1652098,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-09T23:09:10.000Z","date":"2021-03-10","kind":"sale","planned":false,"acquired":false,"shares":4300,"price":108.2156,"value":465327.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of the shares occured in the fiscal year ended December 31, 2021, but the filing of the Form 4 was inadvertently missed during that period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $103.92 to $112.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission (the \"SEC\") staff, Fulgent Genetics, Inc. (the \"Issuer\") or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":358824,"source":{"system":"sec-edgar","filing":"0000950170-24-013414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024013414/ownership.xml","form_type":"5"}},{"id":1657356,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-02-07T00:26:37.000Z","date":"2024-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6719,"price":24.65,"value":165623.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":351722,"source":{"system":"sec-edgar","filing":"0000950170-24-011857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024011857/ownership.xml","form_type":"4"}},{"id":1666975,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-30T21:21:09.000Z","date":"2024-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4683,"price":25.6,"value":119884.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":358441,"source":{"system":"sec-edgar","filing":"0000950170-24-008853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000095017024008853/ownership.xml","form_type":"4"}},{"id":1713099,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-12-14T01:49:45.000Z","date":"2023-12-11","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":26.6895,"value":320274.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $26.61 to $26.92, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":363124,"source":{"system":"sec-edgar","filing":"0001209191-23-058570","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123058570/doc4.xml","form_type":"4"}},{"id":1713098,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-12-14T01:49:45.000Z","date":"2023-12-11","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":26.3179,"value":263179.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $26.26 to $26.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":375124,"source":{"system":"sec-edgar","filing":"0001209191-23-058570","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123058570/doc4.xml","form_type":"4"}},{"id":1720576,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-12-06T23:00:20.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":1779,"price":27.5732,"value":49052.7228,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $27.25 to $27.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":385124,"source":{"system":"sec-edgar","filing":"0001209191-23-057670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123057670/doc4.xml","form_type":"4"}},{"id":1735290,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-11-20T21:30:22.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":1617,"price":27.2511,"value":44065.0287,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $27.02 to $27.54, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":386903,"source":{"system":"sec-edgar","filing":"0001209191-23-056063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123056063/doc4.xml","form_type":"4"}},{"id":1747954,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-11-07T22:10:59.000Z","date":"2023-11-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":7669,"price":26.94,"value":206602.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":388520,"source":{"system":"sec-edgar","filing":"0001209191-23-054622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123054622/doc4.xml","form_type":"4"}},{"id":1754009,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-10-30T21:27:43.000Z","date":"2023-10-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":19833,"price":24.025,"value":476487.825,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units held by the reporting person and assumed by the Issuer on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":396189,"source":{"system":"sec-edgar","filing":"0001209191-23-053874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123053874/doc4.xml","form_type":"4"}},{"id":1784165,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-09-11T20:37:14.000Z","date":"2023-09-07","kind":"sale","planned":false,"acquired":false,"shares":1492,"price":31.4079,"value":46860.5868,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $31.345 to $31.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":416022,"source":{"system":"sec-edgar","filing":"0001209191-23-048935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123048935/doc4.xml","form_type":"4"}},{"id":1801128,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-08-21T20:43:37.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":1307,"price":33.8811,"value":44282.5977,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $33.55 to $34.19, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":417514,"source":{"system":"sec-edgar","filing":"0001209191-23-046720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123046720/doc4.xml","form_type":"4"}},{"id":1814150,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-08-07T21:38:14.000Z","date":"2023-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6198,"price":40.08,"value":248415.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":418821,"source":{"system":"sec-edgar","filing":"0001209191-23-044860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123044860/doc4.xml","form_type":"4"}},{"id":1817000,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-08-03T21:26:53.000Z","date":"2023-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":775,"price":38.83,"value":30093.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."}],"balance_after":425019,"source":{"system":"sec-edgar","filing":"0001209191-23-044509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123044509/doc4.xml","form_type":"4"}},{"id":1865643,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-06-06T21:11:38.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":1433,"price":40.2961,"value":57744.3113,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $39.79 to $40.75, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":425794,"source":{"system":"sec-edgar","filing":"0001209191-23-034803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123034803/doc4.xml","form_type":"4"}},{"id":1885666,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-05-19T20:23:02.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":1320,"price":35.4623,"value":46810.236,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $34.96 to $36.15, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":427227,"source":{"system":"sec-edgar","filing":"0001209191-23-031001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123031001/doc4.xml","form_type":"4"}},{"id":1903353,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-05-05T21:05:17.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6198,"price":29.33,"value":181787.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":428547,"source":{"system":"sec-edgar","filing":"0001209191-23-027775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123027775/doc4.xml","form_type":"4"}},{"id":1906908,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-05-03T21:28:51.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":775,"price":29.9,"value":23172.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."}],"balance_after":434745,"source":{"system":"sec-edgar","filing":"0001209191-23-027090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123027090/doc4.xml","form_type":"4"}},{"id":1976127,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-03-03T21:36:38.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":4045,"price":31.85,"value":128833.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":435520,"source":{"system":"sec-edgar","filing":"0001209191-23-015564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123015564/doc4.xml","form_type":"4"}},{"id":1984838,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-03-01T21:27:48.000Z","date":"2023-02-27","kind":"tax_withholding","acquired":false,"shares":433,"price":32.67,"value":14146.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019."}],"balance_after":439565,"source":{"system":"sec-edgar","filing":"0001209191-23-014113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123014113/doc4.xml","form_type":"4"}},{"id":1991247,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-27T22:23:24.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":741,"price":31.65,"value":23452.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022."}],"balance_after":439998,"source":{"system":"sec-edgar","filing":"0001209191-23-013297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123013297/doc4.xml","form_type":"4"}},{"id":1991246,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-27T22:23:24.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":14573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":440739,"source":{"system":"sec-edgar","filing":"0001209191-23-013297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123013297/doc4.xml","form_type":"4"}},{"id":1991245,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-27T22:23:24.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":2142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022."}],"balance_after":426166,"source":{"system":"sec-edgar","filing":"0001209191-23-013297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123013297/doc4.xml","form_type":"4"}},{"id":2009038,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-17T22:07:22.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":1018,"price":33.99,"value":34601.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019."}],"balance_after":424024,"source":{"system":"sec-edgar","filing":"0001209191-23-010753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123010753/doc4.xml","form_type":"4"}},{"id":2029289,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-07T22:18:53.000Z","date":"2023-02-03","kind":"tax_withholding","acquired":false,"shares":4408,"price":36.21,"value":159613.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":425042,"source":{"system":"sec-edgar","filing":"0001209191-23-007608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123007608/doc4.xml","form_type":"4"}},{"id":2034057,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-03T21:26:23.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":624,"price":34.75,"value":21684.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."}],"balance_after":429450,"source":{"system":"sec-edgar","filing":"0001209191-23-006860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919123006860/doc4.xml","form_type":"4"}},{"id":2099054,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-12-02T22:07:18.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":685,"price":34.3932,"value":23559.342,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $34.0900 to $35.2750, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":430074,"source":{"system":"sec-edgar","filing":"0001209191-22-059453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122059453/doc4.xml","form_type":"4"}},{"id":2110908,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-11-18T21:20:27.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":1306,"price":35.8906,"value":46873.1236,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $35.515 to $36.370, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":430759,"source":{"system":"sec-edgar","filing":"0001209191-22-057844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122057844/doc4.xml","form_type":"4"}},{"id":2121565,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-11-10T02:04:35.000Z","date":"2022-11-07","kind":"grant","acquired":true,"shares":220816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"At the effective time of the Merger, each issued and outstanding share of Fulgent Pharma preferred stock was converted into 0.02314 shares of Fulgent Genetics common stock, par value $0.0001 per share. Of the 220,816 shares of common stock issued to Hsieh Family Dynasty Trust, dated January 27, 2010 (the \"Dynasty Trust\") in connection with the Merger, of which 104,098 shares are currently being held in escrow and following the expiration of the indemnification periods set forth in the Merger Agreement, shall be issued pro rata to the Trust in accordance with the terms of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the \"Trust\"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein."}],"balance_after":220816,"source":{"system":"sec-edgar","filing":"0001209191-22-056317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122056317/doc4.xml","form_type":"4"}},{"id":2121564,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-11-10T02:04:35.000Z","date":"2022-11-07","kind":"grant","acquired":true,"shares":129309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 (the \"Merger Agreement\") by and among Fulgent Genetics, Inc. (\"Fulgent Genetics\"), FG Merger Sub, Inc. (\"FG\"), Fulgent Pharma Holdings, Inc. (\"Fulgent Pharma\"), and the stockholders listed therein, FG merged with and into Fulgent Pharma (the \"Merger\"), with Fulgent Pharma being the surviving corporation following the Merger. At the effective time of the Merger (the \"Effective Time\"), each award of restricted stock units (\"RSUs\") based on Fulgent Pharma common stock that was outstanding immediately prior to the Effective Time (\"Fulgent Pharma RSUs\") was assumed and converted into the right to receive RSUs based on the common stock of Fulgent Genetics with the same terms and conditions as the Fulgent Pharma RSUs immediately prior to the Effective Time, subject to the applicable exchange ratio."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) Twenty-five percent (25%) of the shares subject to RSUs reported herein will vest on the first anniversary of the date of the award, October 26, 2022, and 1/16th of the shares will vest every three months over the remaining 36-month period, subject to continued service for Issuer on each vesting date."}],"balance_after":432065,"source":{"system":"sec-edgar","filing":"0001209191-22-056317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122056317/doc4.xml","form_type":"4"}},{"id":2123733,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-11-07T22:08:09.000Z","date":"2022-11-03","kind":"tax_withholding","acquired":false,"shares":6198,"price":37.89,"value":234842.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2020."}],"balance_after":302756,"source":{"system":"sec-edgar","filing":"0001209191-22-055974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122055974/doc4.xml","form_type":"4"}},{"id":2126328,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-11-03T20:52:29.000Z","date":"2022-11-01","kind":"tax_withholding","acquired":false,"shares":775,"price":40.25,"value":31193.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."}],"balance_after":308954,"source":{"system":"sec-edgar","filing":"0001209191-22-055527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122055527/doc4.xml","form_type":"4"}},{"id":2169315,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-09-01T21:05:46.000Z","date":"2022-08-30","kind":"sale","acquired":false,"shares":675,"price":44.183,"value":29823.525,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $43.90 to $44.93, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":309729,"source":{"system":"sec-edgar","filing":"0001209191-22-048269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122048269/doc4.xml","form_type":"4"}},{"id":2178740,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2546,"kind":"person","name":"Xie Jian","position":1,"cik":"0001819718","reported_name":"Xie Jian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2022-08-19T21:06:56.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":1414,"price":48.8945,"value":69136.823,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $48.67 to $49.02, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":310404,"source":{"system":"sec-edgar","filing":"0001209191-22-046869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819718/000120919122046869/doc4.xml","form_type":"4"}}],"next_cursor":"2022-08-19T21:06:56.000000Z,2178740"}